Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Whittaker

Showing results (281-290 of 286) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 286 results.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidonesHelen F Boyd, Stephen C M Fell, Deirdre M B Hickey, et al.
Nature Communications|June 8, 2024
The Legionella collagen-like protein employs a distinct binding mechanism for the recognition of host glycosaminoglycansSaima Rehman, Anna Katarina Antonovic, Ian E McIntire, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2H F Boyd, S C Fell, S T Flynn, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangementL M Pratt, R P Beckett, C L Bellamy, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Science (New York, N.Y.)|December 7, 2019
Design of an in vitro biocatalytic cascade for the manufacture of islatravirMark A Huffman, Anna Fryszkowska, Oscar Alvizo, et al.
Pageof 29

Showing results (281-290 of 286) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 286 results.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Potent, orally active inhibitors of lipoprotein-associated phospholipase A(2): 1-(biphenylmethylamidoalkyl)-pyrimidonesHelen F Boyd, Stephen C M Fell, Deirdre M B Hickey, et al.
Nature Communications|June 8, 2024
The Legionella collagen-like protein employs a distinct binding mechanism for the recognition of host glycosaminoglycansSaima Rehman, Anna Katarina Antonovic, Ian E McIntire, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2H F Boyd, S C Fell, S T Flynn, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangementL M Pratt, R P Beckett, C L Bellamy, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in manJosie A Blackie, Jackie C Bloomer, Murray J B Brown, et al.
Science (New York, N.Y.)|December 7, 2019
Design of an in vitro biocatalytic cascade for the manufacture of islatravirMark A Huffman, Anna Fryszkowska, Oscar Alvizo, et al.
Pageof 29